Status:
COMPLETED
Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Chronic Neuropathic Pain.
Lead Sponsor:
Pfizer
Conditions:
Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Evaluate long-term safety and efficacy of pregabalin in patients with chronic neuropathic pain.
Eligibility Criteria
Inclusion
- Must have met the inclusion criteria for the preceding double-blind BID study in diabetic neuropathy or postherpetic neuralgia.
- Must have received study medication under double-blind conditions.
Exclusion
- Patients cannot participate if they experienced a serious adverse event during the previous double-blind BID study which was determined to be related to the study medication.
Key Trial Info
Start Date :
October 1 2001
Trial Type :
INTERVENTIONAL
End Date :
August 1 2005
Estimated Enrollment :
325 Patients enrolled
Trial Details
Trial ID
NCT00141362
Start Date
October 1 2001
End Date
August 1 2005
Last Update
January 1 2007
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.